Amarin Corp Plc (AMRN)

[couldbebetter]

What is frustrating is that the group of people most severely affected
by COVID-19 is the same group that is most at risk for CVD. Why
management has not figured out a way to exploit this situation is
bizarre. Management should use this pandemic as a valid reason to
get the word out that Vascepa will help keep patients in a much
better situation should they be exposed to COVID-19. Instead,
management makes excuses that sales reps cannot visit doctor's
offices. How about a sales rep simply explaining that COVID-19
should be a good reason to insure that the doctor's patients are
more likely to survive COVID-19 if they are on Vascepa? Strange
that such a stunning opportunity to promote Vascepa aggressively
is ignored by this management. Maybe JT is afraid the FDA may
see that as somehow promoting off label. What AMRN needs is a
CEO who is BOLD, ARTICULATE, and COMPETENT. What we have now is
a CEO who seems the exact opposite of those qualities. Same goes
for the BOD.